Tue. Mar 3rd, 2020


Shenango Valley Makers

Aspect Biosystems closes $20 million Series A funding round

Canadian 3D bioprinting technology company Aspect Biosystems has announced a $20 million Series A financing round to advance its technology for 3D bioprinting human tissue. The round, led by venture capital firm Radical Ventures, featured new and existing investors, including Pangaea Ventures, Pallasite Ventures, and Rhino Ventures.  Leveraging the newly raised capital, Aspect will focus […]

Go to Source
Author: Anas Essop